In the Boardroom
Refine Search
Pharmaceutical
US-Israeli company Immune Pharmaceuticals has appointed Daniel Kazado chairman of the board, succeeding Daniel Teper. 15 December 2014
Biotechnology
Denmark-based biotech company Zealand Pharma announced today that senior vice president and chief business officer, Arvind Hundal, has stepped down to pursue other opportunities outside the company. 15 December 2014
Biotechnology
The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its founder Cristianne Rijcken as chief executive of the company. 15 December 2014
Pharmaceutical
Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following the company’s launch in the region. 11 December 2014
Biotechnology
RNA therapy specialist RaNA Therapeutics has appointed Ronald Renaud as chief executive. 11 December 2014
Biotechnology
Biopharma commpany Ardelyx has appointed Jeremy Caldwell as executive vice president and chief scientific officer. 11 December 2014
Biotechnology
US biotech company Celgene has appointed Wim Souverijns as vice president general manager for the UK and Ireland. 11 December 2014
Biotechnology
Late-stage biopharma company Soligenix has appointed Oreola Donini as senior vice president and chief scientific officer. 10 December 2014
Pharmaceutical
Israel-based Teva Pharmaceuticals has appointed Yitzhak Peterburg as chairman of the board of directors. 27 November 2014
Pharmaceutical
PTC Therapeutics appoints Tuyen Ong senior vice president, head of clinical development and research
Pharma company PTC Therapeutics has appointed Tuyen Ong as senior vice president, head of clinical development and translational research. 27 November 2014
Pharmaceutical
Danish CNS specialist Lundbeck this morning announced the resignation of its chief executive, Ulf Wiinberg, with immediate effect. 24 November 2014
Pharmaceutical
The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole, has resigned, after 22 years with the company. 21 November 2014
Pharmaceutical
Belgian drug developer Ablynx has announced the appointment of Johan Heylen as chief commercial officer. 18 November 2014
Pharmaceutical
Ireland-headquartered generics major Actavis has appointed Maria Teresa (Tessa) Hilado as chief financial officer. 12 November 2014
Pharmaceutical
Global specialty pharma company Reckitt Benckiser has appointed Cary Claiborne as chief financial officer. 4 November 2014
Pharmaceutical
Rare disease specialist aTyr Pharma has appointed Fred Ramsdell as vice president of immunology. 3 November 2014
Biotechnology
Synthetic biology company Synthetic Genomics has appointed Oliver Fetzer as the company’s new chief executive. 29 October 2014
Pharmaceutical
Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion, at a board meeting convened at 8am this morning it decided unanimously to remove Christopher Viehbacher as chief executive of the company. 29 October 2014
Pharmaceutical
Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify rumors that he is to be dismissed, according to a letter published in French business newspaper Les Echos. 28 October 2014
Biotechnology
Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed Warren Sherman as chief medical officer. 23 October 2014
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze